scholarly journals Biological effects of high strength electric fields on small laboratory animals. Interim progress report, March 9, 1976--September 8, 1976

1976 ◽  
Author(s):  
R.D. Phillips ◽  
W.T. Kaune ◽  
J.R. Decker ◽  
D.L. Hjeresen
Keyword(s):  
Electric Fields ◽  
Biological Effects ◽  
High Strength ◽  
Progress Report ◽  
Laboratory Animals ◽  
Small Laboratory

Possible Biological Effects of 50-Hz Electric Fields: A Progress Report

1985 ◽  
Vol 4 (1) ◽  
pp. 177-194 ◽  
Author(s):  
R. Conti ◽  
P. Nicolini ◽  
P. Cerretelll ◽  
V. Margonato ◽  
A. Veicsteinas
Keyword(s):  
Electric Fields ◽  
Biological Effects ◽  
Progress Report

A METHOD FOR MEASURING THE EFFECTS OF ACID BEVERAGES ON THE TEETH OF SMALL LABORATORY ANIMALS

Science ◽  
1945 ◽  
Vol 102 (2651) ◽  
pp. 404-405 ◽  
Author(s):  
J. S. RESTARSKI ◽  
R. A. GORTNER ◽  
C. M. MCCAY
Keyword(s):  
Laboratory Animals ◽  
Small Laboratory

The current state of mycotoxin biomarker development in humans and animals and the potential for application to plant systems

2011 ◽  
Vol 4 (3) ◽  
pp. 257-270 ◽  
Author(s):  
T. Baldwin ◽  
R. Riley ◽  
N. Zitomer ◽  
K. Voss ◽  
R. Coulombe Jr. ◽  
...  
Keyword(s):  
Disease Risk ◽  
Biological Effects ◽  
Fusarium Verticillioides ◽  
Laboratory Animals ◽  
Plant Tissues ◽  
Living Plant ◽  
Disease Symptoms ◽  
Mechanisms Of Toxicity ◽  
Livestock Feeds ◽  
Commercially Important

Filamentous fungi that contaminate livestock feeds and human food supply often produce toxigenic secondary metabolites known as mycotoxins. Among the hundreds of known mycotoxins, aflatoxins, deoxynivalenol, fumonisins, ochratoxin A and zearalenone are considered the most commercially important. Intense research on these mycotoxins, especially aflatoxin, has resulted in the development of 'biomarkers' used to link exposure to disease risk. In the case of aflatoxin this effort has led to the discovery of both exposure and mechanism-based biomarkers, which have proven essential for understanding aflatoxin's potential for causing disease in humans, including subtle effects on growth and immune response. Fumonisin biomarkers have also been used extensively in farm and laboratory animals to study the fumonisin-induced disruption of cellular and systemic physiology which leads to disease. This review summarises the status of mycotoxin biomarker development in humans and animals for the commercially important mycotoxins. Since the fungi responsible for the production of these mycotoxins are often endophytes that infect and colonise living plant tissues, accumulation of mycotoxins in the plant tissues may at times be associated with development of plant disease symptoms. The presence of mycotoxins, even in the absence of disease symptoms, may still have subtle biological effects on the physiology of plants. This review examines the question of whether or not the knowledge gained from mechanistic studies and development of biomarkers in animal and human systems is transferable to the study of mycotoxin effects on plant systems. Thus far, fumonisin has proven amenable to development of mechanism-based biomarkers to study maize seedling disease caused by the fumonisin producer, Fusarium verticillioides. Expanding our knowledge of mechanisms of toxicity and the overt and subtle effects on animal, human, and plant systems through the identification and validation of biomarkers will further our ability to monitor and limit the damage and economic impact of mycotoxins.

Sign in / Sign up

Export Citation Format

Share Document